Bispecific T cell activating antigen binding molecules

PK201200542A0Active Publication Date: 2012-09-26ROCHE GLYCART AG
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
ROCHE GLYCART AG
Filing Date
2012-08-16
Publication Date
2012-09-26
Patent Text Reader

Abstract

The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules.The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to pharmaceutical composition comprising these bispecific antigen binding molecules.
Need to check novelty before this filing date? Find Prior Art